Atlas Trials

CD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study

Clinical trial NCT07072494 · RECRUITING

Trial details

NCT number
NCT07072494
Sponsor
Zhujiang Hospital
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute Lymphoblastic Leukemia
Start date
2025-07-19
Primary completion
2027-03-19
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.